Pantriozyme (Pancreatin)

Pancreatin, the active ingredient in Pantriozyme, is a digestive enzyme preparation presented as a pancreatic enzyme replacement therapy for oral use. It aids digestion in patients with exocrine pancreatic insufficiency, including those with cystic fibrosis, chronic pancreatitis, and post‑surgical states. GNH USA supplies Pantriozyme as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Pantriozyme as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Pantriozyme is a pancreatic enzyme replacement that acts on the digestive system to improve nutrient breakdown.

- Exocrine pancreatic insufficiency: Improves digestion of fats, proteins and carbohydrates. - Cystic fibrosis‑related pancreatic insufficiency: Enhances absorption of dietary nutrients. - Chronic pancreatitis: Supports digestive function when pancreatic secretion is reduced. - Post‑surgical pancreatic insufficiency: Aids digestion after procedures that reduce pancreatic tissue.

Pantriozyme may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal discomfort - Flatulence - Nausea - Diarrhoea - Constipation - Mild abdominal cramping

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling, difficulty breathing) - Pancreatitis (rare) - Severe abdominal pain - Persistent vomiting - Intestinal obstruction (rare)

Pantriozyme should be used with caution in several circumstances.

- Adjust dosage: Tailor the intake to individual digestive needs. - Monitor the presence of allergic reactions and the ... ... ... ... ... ... ... ... ...  …  ....  d …  .... \\  ... … … \